Juvederm Dermal Fillers

Juvederm collection of hyaluronic acid dermal fillers from Allergan including Voluma XC for cheek volumization, Vollure XC for moderate to severe facial folds, Volbella XC for lip enhancement and perioral lines, and Ultra XC for lip volume. Each formulation is tailored to its target area and depth of injection. Results may last one to eighteen months depending on the product and area treated.

Shiny Laser Skin Clinic uses the Juvederm collection of hyaluronic acid dermal fillers from Allergan — a range of FDA-approved gel formulations engineered with Allergan's proprietary VYCROSS and HYLACROSS cross-linking technologies to provide different rheological properties matched to specific facial tissue planes and treatment goals. The four primary products offered at the clinic are: Juvederm Voluma XC, formulated with a high-viscosity, high-lift-capacity gel using VYCROSS technology for deep injection into the cheek and midface to restore the youthful convex projection of the malar eminence that is lost with age-related volume depletion — results from Voluma XC are associated with lasting up to two years; Juvederm Vollure XC (also VYCROSS), a medium-viscosity gel for injection into moderate to severe nasolabial folds and marionette lines, providing fold softening with flexible gel integration into dynamic tissue areas — results associated with lasting up to eighteen months; Juvederm Volbella XC, a fine-particle gel for the delicate lip tissue and perioral line area, providing subtle lip definition, volume enhancement, and vertical lip line improvement — results associated with lasting up to one year; and Juvederm Ultra XC, a higher-viscosity lip filler for patients seeking more pronounced lip volume and projection. All Juvederm formulations are pre-mixed with lidocaine hydrochloride (the XC designation) to improve patient comfort during injection. The treating injector selects the appropriate product for each anatomical zone based on tissue characteristics, desired outcome, and the patient's individual facial anatomy reviewed at consultation. Post-treatment mild swelling and potential bruising at injection sites typically resolve within three to seven days.